Evidence map›Paper›PMID 23277143›Full record

ArticleFree radical biology & medicine2013

Quantitative site-specific reactivity profiling of S-nitrosylation in mouse skeletal muscle using cysteinyl peptide enrichment coupled with mass spectrometry.

Dian Su, Anil K Shukla, Baowei Chen, Jong-Seo Kim, Ernesto Nakayasu, Yi Qu, Uma Aryal, Karl Weitz, Therese R W Clauss, Matthew E Monroe and 5 more

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Actin filaments-A target for redox regulation.Cytoskeleton (Hoboken, N.J.) · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Dian SuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.
Anil K Shukla
Baowei Chen
Jong-Seo Kim
Ernesto Nakayasu
Yi Qu
Uma Aryal
Karl Weitz
Therese R W Clauss
Matthew E Monroe
David G Camp
Diana J Bigelow
Richard D Smith
Rohit N Kulkarni
Wei-Jun Qian
Pacific Northwest National Laboratory · USJoslin Diabetes Center · US

Funding

WORKSHOP AND TRAINING ACTIVITIESP41RR018522 · NCRR · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2003 to 2011
$25.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
A Universal Multiplex Assay System for High-Throughput Clinical ApplicationsDP2OD006668 · OD · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI QIAN, WEI-JUN · 2009 to 2009
$2.1M
Proteomics Studies of Type 2 Diabetes Using Knockout Mouse ModelsR01DK074795 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2008 to 2012
$2.0M
NCRR NIH HHS P41 RR018522NIDDK NIH HHS R01 DK074795NIDDK NIH HHS R01DK074795NIGMS NIH HHS P41 GM103493NIGMS NIH HHS P41GM103493NIH HHS DP2 OD006668NIH HHS DP2OD006668
6 · The paper itself

Abstract

S-nitrosylation, the formation of S-nitrosothiol (SNO), is an important reversible thiol oxidation event that has been increasingly recognized for its role in cell signaling. Although many proteins susceptible to S-nitrosylation have been reported, site-specific identification of physiologically relevant SNO modifications remains an analytical challenge because of the low abundance and labile nature of this modification. Herein we present further improvement and optimization of the recently reported resin-assisted cysteinyl peptide enrichment protocol for SNO identification and its application to mouse skeletal muscle to identify specific cysteine sites sensitive to S-nitrosylation by a quantitative reactivity profiling strategy. Our results indicate that the protein- and peptide-level enrichment protocols provide comparable specificity and coverage of SNO-peptide identifications. S-nitrosylation reactivity profiling was performed by quantitatively comparing the site-specific SNO modification levels in samples treated with S-nitrosoglutathione, an NO donor, at two different concentrations (i.e., 10 and 100 μM). The reactivity profiling experiments led to the identification of 488 SNO-modified sites from 197 proteins with specificity of ∼95% at the unique peptide level, i.e., ∼95% of enriched peptides contain cysteine residues as the originally SNO-modified sites. Among these sites, 281 from 145 proteins were considered more sensitive to S-nitrosylation based on the ratios of observed SNO levels between the two treatments. These SNO-sensitive sites are more likely to be physiologically relevant. Many of the SNO-sensitive proteins are localized in mitochondria, contractile fiber, and actin cytoskeleton, suggesting the susceptibility of these subcellular compartments to redox regulation. Moreover, these observed SNO-sensitive proteins are primarily involved in metabolic pathways, including the tricarboxylic acid cycle, glycolysis/gluconeogenesis, glutathione metabolism, and fatty acid metabolism, suggesting the importance of redox regulation in muscle metabolism and insulin action.

Indexed as

Actin CytoskeletonAnimalsContractile ProteinsCysteineMaleMass SpectrometryMiceMice, Inbred C57BLMitochondriaMuscle, SkeletalOxidation-ReductionPeptidesProteomicsSignal TransductionS-NitrosoglutathioneS-NitrosothiolsContractile ProteinsCysteinePeptidesS-NitrosoglutathioneS-Nitrosothiols

Identifiers

PMID23277143
PMCPMC3771501
OpenAlexW1984892916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.